Each vial is securely sealed to maintain product integrity and support professional laboratory research applications
Activation of NRF2 prevents tissue damage under pathological conditions 59
The FDAs approval was based on results from the Phase III CheckMate901 trial, where the combo regimen demonstrated a statistically significant improvement in overall survival and progression-free survival compared to cisplatin-gemcitabine alone, BMS reported
Ingredients: Galactomyces Ferment Filtrate, Glycerin, 1,2-Hexanediol, Water, Methylpropanediol, Butane, Diphenyl Dimethicone, Bis-PEG-18 Methyl Ether Dimethyl Silane, C12-14 Pareth-12, Hydroxyacetophenone, Hydrogenated Lecithin, Sodium Citrate, Polyglyceryl-10 Oleate, Ethylhexylglycerin, Citric Acid, Adenosine, Oryza Sativa Bran Extract, Glutathione, 1,2-Hexanediol, Caprylyl Glycol, Tocopherol, 2-O-Ethyl Ascorbic Acid, Amaranthus Caudatus Seed Extract, Betaine, Hydrolyzed Hyaluronic Acid, Oryza Sativa Extract, Ceramide, Propanediol, Saccharomyces/Rice Ferment Filtrate, Acetyl Hexapeptide-8
After completion of initial consult, a treatment can usually be scheduled in less than 1 week